Status:

SUSPENDED

The Plenaxis® Experience Study

Lead Sponsor:

PRAECIS Pharmaceuticals Inc.

Conditions:

Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

PHASE4

Brief Summary

Praecis is currently conducting a 2000 patient Experience Study; this is a Phase IV commitment postmarketing safety study in the Food and Drug Administration (FDA) indicated population of patients rec...

Detailed Description

This is a postmarketing patient safety study in the FDA indicated population of patients receiving Plenaxis®. On a quarterly basis, patients enrolled in the Plenaxis® Experience Study will have their ...

Eligibility Criteria

Inclusion

  • A subject is eligible to participate in the study if he meets the following criteria:
  • Male ≥ 18 years old with advanced symptomatic prostate cancer for whom LHRH agonist therapy is not appropriate and who refuses surgical castration
  • Has at least one of the following:
  • Risk of neurological compromise due to metastases,
  • Ureteral or bladder outlet obstruction due to local encroachment or metastatic disease or
  • Severe bone pain from skeletal metastases persisting on narcotic analgesia
  • Patients or their legal representatives must be able to read, understand and sign an informed consent form to participate in the trial.

Exclusion

  • Female Patients,
  • Pediatric patients,
  • Patients with known hypersensitivity to any of the components in the abarelix injectable suspension

Key Trial Info

Start Date :

June 1 2004

Trial Type :

INTERVENTIONAL

End Date :

December 1 2008

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT00103623

Start Date

June 1 2004

End Date

December 1 2008

Last Update

September 19 2006

Active Locations (60)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 15 (60 locations)

1

Millenium Therapeutics & Research - Urology Practice

Birmingham, Alabama, United States, 35205

2

Valley Urologic Associates

Goodyear, Arizona, United States, 85338

3

Foundation for Cancer Research and Education

Phoenix, Arizona, United States, 85013

4

Arizona Urologic Specialists

Tucson, Arizona, United States, 85712